IPHA · NASDAQ · Biotechnology

Innate Pharma (ADR)

Develops innate-immunity-based antibody therapies for cancer alongside AstraZeneca and Sanofi collaborations.

$2.22
After-hours close0.00 (0.00%)
At close$2.22(−0.45%)
DateEstimateReportedSurprise
Sep 2026−$0.35
May 2026−$0.16−$0.35−116.4%
Sep 2025−$0.14−$0.29−106.5%
May 2025−$0.27−$0.32−18.3%
Nov 2020−$0.34−$0.15+56.1%

The latest year is open to everyone — the 30 quarters behind it read with an account.

Sign in
May 2020
Nov 2019
May 2019
Jun 2018
Dec 2017
Jun 2017
Dec 2016
Jun 2016
Dec 2015
Jun 2015
Dec 2014
Jun 2014
Dec 2013
Jun 2013
Dec 2012
Jun 2012
Dec 2011
Jun 2011
Dec 2010
Jun 2010
Dec 2009
Jun 2009
Dec 2008
Jun 2008
Dec 2007
Jun 2007
Dec 2006
Jun 2006
Dec 2005
Jun 2005
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Sep 17, 2026−$0.35$5.8M
May 13, 2026−$0.16−$0.35−116.4%$5.7M$4.8M−16.1%
Sep 17, 2025−$0.14−$0.29−106.5%$2.0M$5.7M+192.0%
May 12, 2025−$0.27−$0.32−18.3%$18.2M$285.8K−98.4%
Nov 17, 2020−$0.34−$0.15+56.1%$39.7M$41.3M+4.0%

The latest year is open to everyone — the 30 quarters behind it read with an account.

Sign in
May 12, 2020
Nov 13, 2019
May 15, 2019
Jun 30, 2018
Dec 31, 2017
Jun 30, 2017
Dec 31, 2016
Jun 30, 2016
Dec 31, 2015
Jun 30, 2015
Dec 31, 2014
Jun 30, 2014
Dec 31, 2013
Jun 30, 2013
Dec 31, 2012
Jun 30, 2012
Dec 31, 2011
Jun 30, 2011
Dec 31, 2010
Jun 30, 2010
Dec 31, 2009
Jun 30, 2009
Dec 31, 2008
Jun 30, 2008
Dec 31, 2007
Jun 30, 2007
Dec 31, 2006
Jun 30, 2006
Dec 31, 2005
Jun 30, 2005